Skip to main content

Table 2 Univariate and multivariate analyses for worse cancer-specific survival

From: Impact of salvage cytotoxic chemotherapy on prognosis in patients with recurrence after radical cystectomy: a multi-institutional retrospective study

Variable Category Univariate analysis Multivariate analysis
HR 95% CI P value HR 95% CI P value
Age  ≥ 70 1.04 0.66–1.66 0.86 1.37 0.82–2.28 0.23
 ≤ 69 1.0    1.0   
Sex Female 1.36 0.80–2.30 0.25 1.51 0.82–2.79 0.19
Male 1.0    1.0   
T stage  ≥ pT3 1.47 0.88–2.46 0.14 1.92 1.06–3.46 0.03
 ≤ pT2 1.0    1.0   
Metastasis
 Liver Positive 1.68 1.02–2.77 0.041 2.13 1.17–3.85 0.01
Negative 1.0    1.0   
 Lung Positive 1.21 0.72–2.05 0.47 1.57 0.85–2.91 0.15
Negative 1.0    1.0   
 Lymph node Positive 0.89 0.56–1.42 0.63 0.90 0.53–1.52 0.69
Negative 1.0    1.0   
 Bone Positive 0.89 0.53–1.48 0.66 0.90 0.48–1.69 0.75
Negative 1.0    1.0   
AC Positive 0.76 0.46–1.24 0.27 0.53 0.27–1.03 0.06
Negative 1.0    1.0   
SC Positive 0.67 0.42–1.07 0.096 0.72 0.40–1.29 0.27
Negative 1.0    1.0   
  1. HR hazard ratio, CI confidence interval, TTR time to recurrence, RC radical cystectomy, AC adjuvant chemotherapy, SC salvage cytotoxic chemotherapy